Gene · 22861
Papers3,738
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,738
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of mulberry (Morus alba L.) leaf extract against pro-aggregant tau-mediated inflammation and mitochondrial dysfunction. | Neurochem Int | 2025 | 40876782 | PubTator, text mining | PubMed |
| Unraveling genetic predisposition and oxidative stress in vitiligo development and the role of artificial intelligence (AI) in diagnosis and management. | J Med Biochem | 2025 | 40837363 | PubTator, text mining | PubMed |
| O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolism. | Nat Commun | 2025 | 40830102 | PubTator, text mining | PubMed |
| Junctional epithelial Plakoglobin facilitates intestinal inflammation by p38MAPK-dependent activation of the inflammasome. | Mucosal Immunol | 2025 | 40816453 | PubTator, text mining | PubMed |
| Exploration of shared biomarkers and mechanisms in systemic lupus erythematous and lung cancer via bioinformatics analysis. | J Transl Autoimmun | 2025 | 40810050 | PubTator, text mining | PubMed |
| Improving prediction accuracy in chimeric proteins with windowed multiple sequence alignment. | Comput Struct Biotechnol J | 2025 | 40778312 | PubTator, text mining | PubMed |
| Assembly and activation of the NLRP3 inflammasome and cytokine quantification in response to exercise in adults with different metabolic conditions: a systematic review. | Front Sports Act Living | 2025 | 40761804 | PubTator, text mining | PubMed |
| Cardiovascular Manifestations of Pseudoxanthoma Elasticum. | Cureus | 2025 | 40747192 | PubTator, text mining | PubMed |
| Functional Changes Associated With the Subcellular Localization of the Nuclear Receptor NR4A1. | Biochem Res Int | 2025 | 40746844 | PubTator, text mining | PubMed |
| Targeting NLRP1-CCL8 axis in the leukaemic niche suppresses AML via inhibition of PI3K-AKT signalling. | Br J Haematol | 2025 | 40685774 | PubTator, text mining | PubMed |
| Successful Treatment of Skin Dyskeratosis Due To NLRP1 Mutation Using Baricitinib. | J Clin Immunol | 2025 | 40616725 | PubTator, text mining | PubMed |
| The non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasome through disrupting the DPP9-mediated ternary complex. | PLoS Pathog | 2025 | 40608794 | PubTator, text mining | PubMed |
| p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p. | Cell Death Dis | 2025 | 40593496 | PubTator, text mining | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| Anti-Inflammatory Potential of Essential Oil from the Heart-Wood of the Folk Medicinal Tree Cinnamomum kanehirai Hayata in Macrophages. | Int J Mol Sci | 2025 | 40508226 | PubTator, text mining | PubMed |
| Targeting inflammasomes as an immunotherapeutic strategy for cancer. | J Transl Med | 2025 | 40484954 | PubTator, text mining | PubMed |
| Antibiotics re-booted-time to kick back against drug resistance. | NPJ Antimicrob Resist | 2025 | 40447846 | PubTator, text mining | PubMed |
| NEK7-mediated activation of NLRP1 and NLRP3 inflammasomes in the progression of Gestational Diabetes Mellitus. | Hum Immunol | 2025 | 40435843 | PubTator, text mining | PubMed |
| Anti-Inflammasome Effect of Impressic Acid on Diesel Exhaust Particulate Matter-Induced NLRP1 Inflammasome via the Keap1/p62/Nrf2-Signaling Pathway in Keratinocytes. | Antioxidants (Basel) | 2025 | 40427491 | PubTator, text mining | PubMed |
| Correlation Analysis between Serum NLRP1 Inflammasome and Depression in Acute Stage of Stroke. | Neuroimmunomodulation | 2025 | 40403713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22861/papers?page=7